Pain
Pearl of the Month
Not your ordinary neuropathy
An exam reveals hyperesthesia of both feet, and a hemoglobin A1c level of 7.5.
Conference Coverage
Language barrier may contribute to ob.gyn. pain management disparities
Despite similar pain scores between those whose primary language is English and those with a different primary language, non-English speakers...
Conference Coverage
Lesions in pelvis may be ‘tip of the iceberg’ in endometriosis
Systemic manifestations of the disease have implications for diagnosis and treatment, a researcher suggests.
Conference Coverage
Which comes first in osteoarthritis: The damage or the pain?
Osteoarthritis experts debate whether pain is the result of joint damage or a cause of it.
Applied Evidence
How to help runners steer clear of injury
Assess risk factors, then work to address modifiable ones, such as wearing the right running shoes and building up slowly. Don’t let overweight or...
From the Journals
NSAIDs don’t make COVID-19 worse in hospitalized patients
In a British study, hospitalized patients didn’t fare worse if they’d taken NSAIDs regularly before admission.
Conference Coverage
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
News
FDA OKs higher-dose naloxone nasal spray for opioid overdose
Kloxxado delivers 8 mg of naloxone into the nasal cavity, which is twice as much as the 4 mg of naloxone contained in Narcan.
Feature
The cloudy role of cannabis as a neuropsychiatric treatment
Medical cannabis has been made widely available to patients and has largely outpaced the clinical evidence.
From the Journals
Doctors more likely to prescribe opioids to COVID ‘long-haulers,’ raising addiction fears
The new study “suggests to me that many clinicians still don’t get it,” said Dr. Andrew Kolodny.